{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:22Z","timestamp":1791214042528,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2253,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/j.1365-2230.2009.03227.x","type":"journal-article","created":{"date-parts":[[2009,4,9]],"date-time":"2009-04-09T04:57:51Z","timestamp":1239253071000},"page":"561-565","source":"Crossref","is-referenced-by-count":34,"title":["Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology"],"prefix":"10.1093","volume":"34","author":[{"given":"V.","family":"Madan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Chinoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E. M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study","volume":"85","author":"Stockton","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archderm.138.7.969","article-title":"When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer?","volume":"138","author":"Callen","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB5","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1055-9965.EPI-04-0624","article-title":"Tumor antigen markers for the detection of solid cancers in inflammatory myopathies","volume":"14","author":"Amoura","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0002-9343(86)90036-7","article-title":"Dermatomyositis without creatine kinase elevation. A poor prognostic sign","volume":"80","author":"Fudman","year":"1986","journal-title":"Am J Med"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199905000-00001","article-title":"Influence of age on characteristics of polymyositis and dermatomyositis in adults","volume":"78","author":"Marie","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00002281-199411000-00007","article-title":"Myositis and malignancy","volume":"6","author":"Callen","year":"1994","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1067\/mjd.2003.208","article-title":"Dermatomyositis and malignancy in Tunisia: a multicenter national retrospective study of 20 cases","volume":"48","author":"Mebaz\u00e2a","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/archotol.1995.01890110072013","article-title":"Nasopharyngeal carcinoma with dermatomyositis. Analysis of 12 cases","volume":"121","author":"Peng","year":"1995","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"Systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.bor.0000245721.02512.77","article-title":"Cancer and myositis: new insights into an old association","volume":"18","author":"Levine","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB14","first-page":"2136","article-title":"Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors","volume":"60","author":"Darnell","year":"2000","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0896-6273(93)90077-5","article-title":"Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system","volume":"11","author":"Buckanovich","year":"1993","journal-title":"Neuron"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB16","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1523\/JNEUROSCI.16-03-01114.1996","article-title":"The onconeural antigen Nova-1isa neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies","volume":"16","author":"Buckanovich","year":"1996","journal-title":"J Neurosci"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00002281-200311000-00005","article-title":"Anti-aminoacyl tRNA synthetase immune responses: insights into the pathogenesis of the idiopathic inflammatory myopathies","volume":"15","author":"Levine","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11926-003-0052-2","article-title":"The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses","volume":"5","author":"Ascherman","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/08916930400022681","article-title":"Anti-Mi-2 antibodies","volume":"38","author":"Ghirardello","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB21","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB22","first-page":"169","article-title":"Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome","volume":"35","author":"Legault","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/RHU.0b013e31817d116f","article-title":"Malignancy in the setting of the anti-synthetase syndrome","volume":"14","author":"Rozelle","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jdermsci.2005.09.004","article-title":"Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis","volume":"40","author":"Komura","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A-B-Cw-DRB1 and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies","volume":"85","author":"O\u2019Hanlon","year":"2006","journal-title":"Medicine"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB26","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB27","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140\u2003kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","article-title":"Antibody to signal recognition particle in polymyositis","volume":"33","author":"Targoff","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB29","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","article-title":"Identification of a novel autoantibody reactive with 155 and 140\u2003kDa nuclear proteins in patients with dermatomyositis: an association with malignancy","volume":"46","author":"Kaji","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB31","first-page":"S518","article-title":"Autoantibodies to transcriptional intermediary factor 1-gamma (TIF1-g) in dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2230.2009.03227.x-BIB32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine (Baltimore)"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2009.03227.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2009.03227.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:28:40Z","timestamp":1676366920000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/34\/5\/561\/6625001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03227.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}